U.S. panel advises against aspirin, NSAIDs to prevent colon cancer

A federal task force advised people at risk for colon cancer to avoid taking aspirin or NSAIDs in an attempt to prevent the disease, including those with a family history of colorectal cancer. The U.S. Preventive Services Task Force issued the warning in a journal study, saying daily doses of more than 300 milligrams carry an increased risk of bleeding, stroke or other problems, risks that outweigh the anti-cancer benefits of the drugs.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC